Medifast, Inc. (MED)

Medifast Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	89.3	90.93	94.44	87.69	104.18
Short-Term Investments	77.97	71.42	55.6	-	5.36
Cash & Short-Term Investments	167.27	162.34	150.04	87.69	109.54
Cash Growth	3.04%	8.20%	71.10%	-19.95%	-37.21%
Inventory	20.23	42.42	54.59	118.86	180.04
Other Current Assets	14.18	9.64	19.4	16.24	17.28
Total Current Assets	201.68	214.4	224.03	222.78	306.87
Net Property, Plant & Equipment	38.46	48.68	67.11	75.65	80.59
Other Long-Term Assets	7.83	21.13	18.77	17.78	10.87
Total Assets	247.97	284.21	309.91	316.21	398.33
Accounts Payable	38.36	56.49	86.42	134.69	163.31
Current Portion of Leases	4.6	6.18	5.89	5.78	6.52
Other Current Liabilities	-	1.49	-	0.43	-
Total Current Liabilities	42.96	64.16	92.3	140.89	169.83
Long-Term Leases	6.09	9.94	16.13	20.28	26.02
Total Long-Term Liabilities	6.09	9.94	16.13	20.28	26.02
Total Liabilities	49.05	74.1	108.43	161.17	195.85
Common Stock	0.01	0.01	0.01	0.01	0.01
Treasury Stock	-	-	-	-6.4	-
Additional Paid-in Capital	40.41	33.14	26.57	21.56	12.02
Accumulated Other Comprehensive Income	0.23	0.18	0.25	0.02	0.11
Retained Earnings	158.27	176.78	174.65	139.85	190.33
Shareholders' Equity	198.92	210.11	201.48	155.04	202.47
Total Liabilities & Equity	247.97	284.21	309.91	316.21	398.33
Total Debt	10.69	16.13	22.01	26.05	32.54
Net Cash (Debt)	156.58	146.22	128.03	61.64	77
Net Cash Growth	7.08%	14.21%	107.70%	-19.95%	-52.85%
Net Cash Per Share	14.26	13.34	11.72	5.47	6.52
Book Value	198.92	210.11	201.48	155.04	202.47
Book Value Per Share	18.11	19.17	18.45	13.75	17.14
Tangible Book Value	198.92	210.11	201.48	155.04	202.47
Tangible Book Value Per Share	18.11	19.17	18.45	13.75	17.14

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q